Grab This Bargain Even Cheaper Than Director Aselage Did
March 18, 2019 at 10:17 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 12, BioCryst Pharmaceuticals Inc's Director, Steve Aselage, invested $16,600.00 into 2,000 shares of BCRX, for a cost per share of $8.30..